Quercetin protects against palmitate-induced pancreatic β-cell apoptosis by restoring lysosomal function and autophagic flux. 2022

Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
College of Basic Medical Sciences, North China University of Science and Technology, Tangshan, Hebei, China; Beijing Key Laboratory for Immune-Mediated Inflammatory Diseases, Institute of Medical Science, China-Japan Friendship Hospital, Beijing, China; Hebei Key Laboratory for Chronic Diseases, College of Basic Medical Sciences, North China University of Science and Technology, Tangshan, Hebei, China.

Quercetin, a natural flavonoid, has been reported to prevent pancreatic β-cell apoptosis in animal models of diabetes. However, the underlying mechanism remains unclear. We investigated the mechanisms through which quercetin protects β cells from palmitate-induced apoptosis and determined whether autophagy is involved in this process. We found that quercetin treatment partially reduced palmitate-induced β-cell apoptosis. This protective effect was abolished by pharmacologic inhibition of autophagy and by silencing a key autophagy gene. Further analysis revealed that palmitate treatment promoted the expression of LC3 II, a marker of autophagosomes, but resulted in the blockade of autophagic flux due to lysosome dysfunction. Defective lysosome accumulation can cause lysosomal membrane permeabilization and the release of cathepsins from lysosome into the cytosol that triggers apoptosis. Treatment with quercetin reversed lysosomal dysfunction and promoted autophagosome-lysosome fusion, which restored defective autophagic flux and provoked autophagy. Overall, our results indicate that lysosomal dysfunction is a major factor that contributes to β-cell apoptosis and demonstrates that quercetin improves cell survival by restoring lysosomal function and autophagic flux. This study provides new evidence regarding the anti-apoptotic mechanism of quercetin in the treatment of type 2 diabetes.

UI MeSH Term Description Entries
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D010168 Palmitates Salts and esters of the 16-carbon saturated monocarboxylic acid--palmitic acid. Hexadecanoates,Palmitate
D011794 Quercetin A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. 3,3',4',5,7-Pentahydroxyflavone,Dikvertin
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001343 Autophagy The segregation and degradation of various cytoplasmic constituents via engulfment by MULTIVESICULAR BODIES; VACUOLES; or AUTOPHAGOSOMES and their digestion by LYSOSOMES. It plays an important role in BIOLOGICAL METAMORPHOSIS and in the removal of bone by OSTEOCLASTS. Defective autophagy is associated with various diseases, including NEURODEGENERATIVE DISEASES and cancer. Autophagocytosis,ER-Phagy,Lipophagy,Nucleophagy,Reticulophagy,Ribophagy,Autophagy, Cellular,Cellular Autophagy,ER Phagy
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
May 2017, Diabetes,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
November 2016, The Journal of endocrinology,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
June 2022, Cell biology and toxicology,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
January 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
January 2020, Oxidative medicine and cellular longevity,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
February 2019, Osteoarthritis and cartilage,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
July 2018, Cellular signalling,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
March 2023, International journal of molecular sciences,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
July 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Hao Liu, and Wenling Zhou, and Lan Guo, and Heng Zhang, and Lingling Guan, and Xu Yan, and Yuanyuan Zhai, and Yuan Qiao, and Zai Wang, and Junhua Zhao, and Kangbo Lyu, and Ping Li, and Haitao Wang, and Liang Peng
September 2017, Experimental cell research,
Copied contents to your clipboard!